441 related articles for article (PubMed ID: 34177904)
1. Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders.
Guzel F; Romano M; Keles E; Piskin D; Ozen S; Poyrazoglu H; Kasapcopur O; Demirkaya E
Front Immunol; 2021; 12():666273. PubMed ID: 34177904
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
Karacan İ; Balamir A; Uğurlu S; Aydın AK; Everest E; Zor S; Önen MÖ; Daşdemir S; Özkaya O; Sözeri B; Tufan A; Yıldırım DG; Yüksel S; Ayaz NA; Ömeroğlu RE; Öztürk K; Çakan M; Söylemezoğlu O; Şahin S; Barut K; Adroviç A; Seyahi E; Özdoğan H; Kasapçopur Ö; Turanlı ET
Rheumatol Int; 2019 May; 39(5):911-919. PubMed ID: 30783801
[TBL] [Abstract][Full Text] [Related]
3. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
[TBL] [Abstract][Full Text] [Related]
4. ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era.
Shinar Y; Ceccherini I; Rowczenio D; Aksentijevich I; Arostegui J; Ben-Chétrit E; Boursier G; Gattorno M; Hayrapetyan H; Ida H; Kanazawa N; Lachmann HJ; Mensa-Vilaro A; Nishikomori R; Oberkanins C; Obici L; Ohara O; Ozen S; Sarkisian T; Sheils K; Wolstenholme N; Zonneveld-Huijssoon E; van Gijn ME; Touitou I
Clin Chem; 2020 Apr; 66(4):525-536. PubMed ID: 32176780
[TBL] [Abstract][Full Text] [Related]
5. Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases.
Rusmini M; Federici S; Caroli F; Grossi A; Baldi M; Obici L; Insalaco A; Tommasini A; Caorsi R; Gallo E; Olivieri AN; Marzano A; Coviello D; Ravazzolo R; Martini A; Gattorno M; Ceccherini I
Ann Rheum Dis; 2016 Aug; 75(8):1550-7. PubMed ID: 26386126
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Next-Generation Sequencing Panel for Syndromic and Nonsyndromic Hearing Loss.
Butz M; McDonald A; Lundquist PA; Meyer M; Harrington S; Kester S; Stein MI; Mistry NA; Zimmerman Zuckerman E; Niu Z; Schimmenti L; Hasadsri L; Boczek NJ
J Appl Lab Med; 2020 May; 5(3):467-479. PubMed ID: 32445360
[TBL] [Abstract][Full Text] [Related]
7. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels.
Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B
J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of copy number variant detection from panel-based next-generation sequencing data.
Yao R; Yu T; Qing Y; Wang J; Shen Y
Mol Genet Genomic Med; 2019 Jan; 7(1):e00513. PubMed ID: 30565893
[TBL] [Abstract][Full Text] [Related]
9. Is gene panel sequencing more efficient than clinical-based gene sequencing to diagnose autoinflammatory diseases? A randomized study.
Rama M; Mura T; Kone-Paut I; Boursier G; Aouinti S; Touitou I; Sarrabay G
Clin Exp Immunol; 2021 Jan; 203(1):105-114. PubMed ID: 32909274
[TBL] [Abstract][Full Text] [Related]
10. Rapid Low-Cost Microarray-Based Genotyping for Genetic Screening in Primary Immunodeficiency.
Suratannon N; van Wijck RTA; Broer L; Xue L; van Meurs JBJ; Barendregt BH; van der Burg M; Dik WA; Chatchatee P; Langerak AW; Swagemakers SMA; Goos JAC; Mathijssen IMJ; Dalm VASH; Suphapeetiporn K; Heezen KC; Drabwell J; Uitterlinden AG; van der Spek PJ; van Hagen PM;
Front Immunol; 2020; 11():614. PubMed ID: 32373116
[No Abstract] [Full Text] [Related]
11. Cost-efficient multiplex PCR for routine genotyping of up to nine classical HLA loci in a single analytical run of multiple samples by next generation sequencing.
Ozaki Y; Suzuki S; Kashiwase K; Shigenari A; Okudaira Y; Ito S; Masuya A; Azuma F; Yabe T; Morishima S; Mitsunaga S; Satake M; Ota M; Morishima Y; Kulski JK; Saito K; Inoko H; Shiina T
BMC Genomics; 2015 Apr; 16(1):318. PubMed ID: 25895492
[TBL] [Abstract][Full Text] [Related]
12. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
13. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
14. Clinical validation of targeted next-generation sequencing for inherited disorders.
Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
[TBL] [Abstract][Full Text] [Related]
15. An Easy-to-Use Approach to Detect CNV From Targeted NGS Data: Identification of a Novel Pathogenic Variant in MO Disease.
Corsini S; Pedrini E; Patavino C; Gnoli M; Lanza M; Sangiorgi L
Front Endocrinol (Lausanne); 2022; 13():874126. PubMed ID: 35837302
[TBL] [Abstract][Full Text] [Related]
16. Free-access copy-number variant detection tools for targeted next-generation sequencing data.
Roca I; González-Castro L; Fernández H; Couce ML; Fernández-Marmiesse A
Mutat Res Rev Mutat Res; 2019; 779():114-125. PubMed ID: 31097148
[TBL] [Abstract][Full Text] [Related]
17. Massively parallel and multiplex blood group genotyping using next-generation-sequencing.
Boccoz SA; Fouret J; Roche M; Lachuer J; Legras-Lachuer C; Corgier BP; Marquette CA
Clin Biochem; 2018 Sep; 60():71-76. PubMed ID: 30092181
[TBL] [Abstract][Full Text] [Related]
18. How to prescribe a genetic test for the diagnosis of autoinflammatory diseases?
Rowczenio DM; Lachmann HJ
Presse Med; 2019 Feb; 48(1 Pt 2):e49-e59. PubMed ID: 30665783
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
20. CNV-RF Is a Random Forest-Based Copy Number Variation Detection Method Using Next-Generation Sequencing.
Onsongo G; Baughn LB; Bower M; Henzler C; Schomaker M; Silverstein KA; Thyagarajan B
J Mol Diagn; 2016 Nov; 18(6):872-881. PubMed ID: 27597741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
